| Issue Type | Login |
|---|---|
| Country | Japan |
| Industry | Login |
| Region | Login |
| Maturity Date | 2050-09-09 |
| Par Value | 100000000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 60000.00 |
| Coupon | 1.55 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 60000.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Sumitomo Pharma Co. Ltd. corporate bond has a 1.55% fixed-floating rate rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 60000.00 million JPY and matures on September 09, 2050 with a last coupon date of FEB 28, 2020. |
Sumitomo Pharma Co. Ltd. is a Japanese pharmaceutical company founded in 1897 and headquartered in Osaka, Japan, focusing on the research, development, and manufacturing of innovative pharmaceutical products. The company's portfolio includes a range of therapeutic areas such as psychiatry, neurology, and oncology, with notable products like the antipsychotic agent Latuda and the anti-cancer drug Sumitomo Dainippon Pharma's Epclusa.